Ergoteles’s Rosecliff Acquisition Corp I Unit RCLFU Stock Holding History

Ergoteles’s Portfolio RCLFU Stock Details RCLFU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-19,400	Closed	-$191K	–	2054
2022 Q3	$191K	Hold	19,400	–	–	0.01%	1201
2022 Q2	$191K	Hold	19,400	–	–	0.01%	1349
2022 Q1	$190K	Hold	19,400	–	–	0.01%	1013
2021 Q4	$195K	Hold	19,400	–	–	0.01%	1047
2021 Q3	$192K	Hold	19,400	–	–	0.01%	1017
2021 Q2	$195K	Hold	19,400	–	–	﹤0.01%	1289
2021 Q1	$192K	Buy	+19,400	New	+$195K	0.01%	682

Other funds holding RCLFU

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Ergoteles's RCLFU Position: Q4 2022 in Review

Ergoteles sold out of Rosecliff Acquisition Corp I Unit (RCLFU) in Q4 2022, closing a stake of 19,400 shares — an estimated $191K sold.

Ergoteles first reported a position in RCLFU in Q1 2021 and held it in 7 quarters. The position peaked at $195K in Q4 2021. 3 funds tracked by Wall St. Rank hold RCLFU as of Q4 2022.

Ergoteles reported no remaining Rosecliff Acquisition Corp I Unit position as of Q4 2022 after selling out during the quarter.
Ergoteles sold 19,400 Rosecliff Acquisition Corp I Unit shares in Q4 2022, an estimated $191K.
Ergoteles first reported a position in Rosecliff Acquisition Corp I Unit in Q1 2021 and held it in 7 quarters.
Ergoteles's Rosecliff Acquisition Corp I Unit position peaked at $195K in Q4 2021.
3 funds tracked by Wall St. Rank held Rosecliff Acquisition Corp I Unit as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.